Kenneth C. Carter, President and CEO at AVALON PHARMACEUTICALS INC (AVRX), bought 3,000 shares at $2.99 ($9K) on 2006-08-30, disclosed to the SEC on 2006-08-31.
Open-market purchase of $9k AVRX by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| AVRX | SELL | 2008-01-23 | $5K | — | Filing → |
| AVRX | BUY | 2006-08-24 | $7K | — | Filing → |